Xtant Medical Holdings, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Xtant Medical Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, equals 27% of its market value (net debt). Lower than 87% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-1.1×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 61% of Healthcare companies in United States.
Cash Locked Ratio
$34For every $100 of sales, $34 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $35 tied up three years earlier.
More money tied up than 74% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$18Sales grew 131% in 3 years; of every extra $100 of sales, $18 became extra profit.
Lower than 52% of Healthcare companies in United States.
Asset Productivity Ratio
+131% / +56%In 3 years sales changed by +131% while total assets changed by +56%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
0.9×Debt due within a year is covered 0.9 times by its yearly operating cash.
Higher than 71% of Healthcare companies in United States.
Cash Cushion Ratio
−27%Debt, after subtracting cash, equals 27% of its market value (net debt).
Lower than 87% of Healthcare companies in United States.
Tangible Assets Ratio
93%Of every $100 the company owns, $93 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 67% of Healthcare companies in United States.
Tangible Net Worth Ratio
87%Of every $100 of net worth, $87 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 70% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Xtant Medical Holdings, Inc. made a loss over the last year. Xtant Medical Holdings, Inc. owes $0.50 for every $1 it owns. Xtant Medical Holdings, Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossXtant Medical Holdings, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.09The share price is 1.09 times Xtant Medical Holdings, Inc.'s book value per share, lower than 77% of Healthcare companies in United States.
Market cap
$44 MThe total market value of all of Xtant Medical Holdings, Inc.'s shares at today's price (share price × number of shares), smaller than 75% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$40 MWhat Xtant Medical Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.29Net worth divided by the number of shares. The share price of $0.31 is 1.1 times this, which is the P/B above.
Return on equity (ROE)
-25.2%Xtant Medical Holdings, Inc. lost 25.2% of its shareholders' money over the last year, higher than 63% of Healthcare companies in United States.
Owes vs Owns
0.50×Xtant Medical Holdings, Inc. owes $0.50 for every $1 it owns (low), higher than 55% of Healthcare companies in United States.
Dividend yield
NoneXtant Medical Holdings, Inc. does not currently pay a dividend.
Revenue growth
+14%Revenue rose 14% in the year to Dec 2025, and grew 32% a year on average over 3 years.
Profit growth
Back to profitXtant Medical Holdings, Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Profit margin
3.7%Xtant Medical Holdings, Inc. keeps $4 of every $100 of revenue as net profit.
Cash quality
2.5×Cash from Xtant Medical Holdings, Inc.'s business was 2.5× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
2.0×Xtant Medical Holdings, Inc.'s operating profit covered its interest costs 2.0 times in the year to Dec 2025.
Cash vs debt
Net debtXtant Medical Holdings, Inc. had $12 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Xtant Medical Holdings, Inc.: $44 M ÷ $40 M (30 Jun 2026) = 1.1.
What is Xtant Medical Holdings, Inc.'s return on equity?
Xtant Medical Holdings, Inc. lost 25.2% of its shareholders' money over the last year, higher than 63% of Healthcare companies in United States.
How much does Xtant Medical Holdings, Inc. owe compared with what it owns?
Xtant Medical Holdings, Inc. owes $0.50 for every $1 it owns (low), higher than 55% of Healthcare companies in United States.
Does Xtant Medical Holdings, Inc. pay a dividend?
No. Xtant Medical Holdings, Inc. does not currently pay a dividend.
Is Xtant Medical Holdings, Inc.'s revenue growing?
Revenue rose 14% in the year to Dec 2025, and grew 32% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.